REGAVIRUMAB

UNII: STG2Q92FWF
Preferred Substance Name: REGAVIRUMAB

153101-26-9
IMMUNOGLOBULIN G 1 (HUMAN MONOCLONAL .GAMMA.-CHAIN ANTI-HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN HERPESVIRUS 5 GLYCOPROTEIN B) (HUMAN MONOCLONAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER
MCA-C23
REGAVIRUMAB [INN]
REGAVIRUMAB [JAN]
TI-23

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

REGAVIRUMAB

Synonyms and Mappings

Resources

Note